General Manager (Senior Director), Americas - US South

Tennessee, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, HealthcareIndustries

Requirements

The General Manager requires significant leadership experience in driving business success within a defined geography, including P&L responsibilities and managing multiple customer-facing functions. They must be capable of setting strategic direction, aligning resources, and achieving financial and strategic goals. Experience in developing commercial plans, go-to-market strategies, and forecasting sales is essential. The role also demands the ability to engage with government and industry leaders, shape market opportunity views, and recruit/retain top talent. A strong understanding of the life sciences and clinical markets is implied.

Responsibilities

The General Manager will lead a US geography with multiple states, overseeing district sales, inside sales, corporate account sales, and sequencing specialists. They are responsible for aligning and leveraging commercial execution resources to maximize market adoption and success, ensuring attainment of financial and strategic goals. This includes driving accelerated revenue growth and market penetration in both life sciences and clinical markets. The role involves leading the genomics ecosystem within the region by developing commercial plans to meet market demands, directing sales, and partnering with marketing on go-to-market strategies and sales forecasts. The General Manager will manage the P&L, decide on customer-facing resources, collaborate with global and regional counterparts on strategic matters, build the Illumina brand, develop and execute KOL and government strategies, shape the view on new market opportunities, and cultivate a strong talent development culture by identifying, recruiting, and retaining top talent.

Skills

Strategic Planning

Business Development

Sales Management

P&L Management

Leadership

Market Analysis

Customer Relationship Management

Genomic Technology

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free